Why Dava Pharmaceuticals Got Warning Letter

  Dava pharmaceuticals is a subsidiary of Endo International plc an American Irish-domiciled generics and specialty branded pharmaceutical company. In 2014, Endo International reached a $575 million agreement  to acquire DAVA Pharmaceuticals, a privately-held company specializing in marketed, pre-launch, and pipeline generic pharmaceuticals. The Company got an FDA warning letter for some infractions related to its […]

error: Protected Content!!